NOTV Stock Analysis: Buy, Sell, or Hold?
NOTV - Inotiv, Inc. Common Stock
$0.29
-0.02 (-5.89%)
▼
5d:
-4.31%
30d:
-1.39%
90d:
+2.18%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 20, 2026
1d
Get Alerted When NOTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NOTV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NOTV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NOTV is currently trading at $0.29, which is considered slightly high relative to its 30-day fair value range of $0.25 to $0.32.
Technical Outlook: Technically, NOTV is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.34. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.25 (+1016.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NOTV is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.34. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.25 (+1016.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.25 -
$0.32
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 1016.8% below Wall St target ($3.25)
Trading Range Analysis
30-Day Trading Range
$0.25 -
$0.32
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.34
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.16
Wall Street Target
$3.25
(+1016.8%)
Revenue Growth (YoY)
-5.4%
Profit Margin
-17.1%
Share & Embed Analysis
Last updated: May 18, 2026 8:37 AM ET
Data refreshes hourly during market hours. Next update: 9:37 AM
Data refreshes hourly during market hours. Next update: 9:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Beth A Taylor
SELL
2888 shares
2026-02-17
John E Sagartz
SELL
2119 shares
2026-02-17
Robert Jr. Leasure
SELL
16810 shares
2026-02-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
